Susan McCammon
Papers
1
Total Citations
15
H-Index
1
About
Dr. Susan McCammon is a pioneering surgeon-scientist whose research lies at the critical intersection of head and neck oncology, fluorescence-guided surgery, and precision medicine. Her most significant contribution is the development and clinical translation of targeted molecular imaging agents, most notably panitumumab-IRDye800CW, which enables real-time visualization of cancer cells during transoral robotic surgery (TORS) for oropharyngeal squamous cell carcinoma. This work directly addresses the challenge of limited tactile feedback in robotic procedures, allowing surgeons to achieve more complete tumor resections while preserving healthy tissue. Her landmark 2024 interim Phase II results, already garnering 15 citations, demonstrate the clinical viability of this approach. Beyond this, Dr. McCammon's research portfolio encompasses the optimization of surgical outcomes through novel imaging technologies and the integration of targeted therapies with surgical interventions. Her work has fundamentally advanced the field of image-guided oncologic surgery, offering patients improved functional outcomes and potentially reducing recurrence rates. As a leader in this rapidly evolving domain, Dr. McCammon continues to bridge the gap between laboratory innovation and clinical practice, setting new standards for precision in head and neck cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1